DR. VIDYA SESHADRI M.D. NPI 1184843369

NPI Details

DR. Vidya Seshadri, M.D. is a hematology and oncology internal medicine in Bowling Green, KY with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Vidya Seshadri, M.D. NPI is 1184843369. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

201 PARK ST
BOWLING GREEN, KY
ZIP 42101-759
Phone: (270) 781-5111
Fax: (270) 780-0474

The NPI 1184843369 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Ct scan of chest with contrast (HCPCS:71260)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Unclassified drugs (HCPCS:J3490)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Magnesium level (HCPCS:83735)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• X-ray of chest, 2 views (HCPCS:71046)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Collection of blood sample from implanted device (HCPCS:36591)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Phosphate level (HCPCS:84100)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Injection of drug or substance into vein (HCPCS:96374)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Bacterial colony count, urine (HCPCS:87086)
• Ct scan of chest without contrast (HCPCS:71250)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Drawing of blood for a medical problem (HCPCS:99195)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Vitamin d-3 level (HCPCS:82306)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Limited ultrasound scan of 1 breast (HCPCS:76642)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)

The enumeration date for this NPI number is 4/25/2007 and was last updated on 8/20/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.